Pricing Log in Create free account
Saturday 17 October 2026 Export EW’s income statement to Excel — free account

Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

86.60 1.50 −1.70%
Market cap
$50.8B
P/E
49.8×
Fwd P/E
30.7×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Edwards Lifesciences Corporation (EW) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Edwards Lifesciences Corporation (EW) trades at a price to free cash flow of 35.6×. Over the past ten years it has ranged from 14.3× (January 2015) to 226× (April 2024); the current reading is higher than 9% of that period. That is above the Medical Devices industry median of 23.7× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 38.2× (77.56%)
FY2024 170× 133.75%
FY2023 72.8× 50.36%
FY2022 48.4× (15.90%)
FY2021 57.6× (35.12%)
FY2020 88.8× 65.28%
FY2019 53.7× 14.82%
FY2018 46.8× 62.79%
FY2017 28.7× (31.75%)
FY2016 42.1× 6.69%

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 37.1× (15.14%)
Mar 2026 43.8× 14.59%
Dec 2025 38.2× (34.96%)
Sep 2025 58.7× (28.62%)
42 more quarters

Against its own ten years

Low 14.3× High 226×
Ten-year median 51.6×
Current reading's percentile 9

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 13.3×
ZBH Zimmer Biomet Holdings, Inc. compare 17.6×
BSX Boston Scientific Corporation compare 18.0×
MDT Medtronic PLC compare 19.8×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc compare 23.2×
DXCM DexCom, Inc. compare 23.4×
SYK Stryker Corporation compare 24.0×
EW Edwards Lifesciences Corporation 35.6×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on EW